Publication & Citation Trends
Most Cited Works
Publications
74 total
Memantine and Acetylcholinesterase Inhibitor Use in Alzheimer’s Disease Clinical Trials: Potential for Confounding by Indication
Cited by 10
Semantic Scholar
SAT-429 Final Results from the First in Man Phase 1 Clinical Trial of CRN00808, an Orally Bioavailable sst2-Selective, Nonpeptide Somatostatin Biased Agonist, for the Treatment of Acromegaly: Safety, Pharmacokinetics, Pharmacodynamics, and Midazolam Drug Interaction in Healthy Volunteers OA
Cited by 6
Semantic Scholar
Safety and Efficacy of Edonerpic Maleate for Patients With Mild to Moderate Alzheimer Disease: A Phase 2 Randomized Clinical Trial. OA
Cited by 36
Semantic Scholar
Memantine and Cholinesterase Inhibitor Use in Alzheimer Disease Trials: Potential for Confounding by Indication (P6.178)
Cited by 1
Semantic Scholar
A phase I, first-in-human, dose escalation study of intravenous TK216 in patients with relapsed or refractory Ewing sarcoma.
Cited by 7
Semantic Scholar
Effects of the Acetylcholine Release Agent ST101 with Donepezil in Alzheimer’s Disease: A Randomized Phase 2 Study
Cited by 22
Semantic Scholar
Oral IDN‐6556, an antiapoptotic caspase inhibitor, may lower aminotransferase activity in patients with chronic hepatitis C OA
Cited by 194
Semantic Scholar
Research Topics
Alzheimer's disease research and treatments
(19)
Cell death mechanisms and regulation
(13)
Prion Diseases and Protein Misfolding
(10)
Synthesis and biological activity
(8)
Cholinesterase and Neurodegenerative Diseases
(8)
Frequent Co-Authors
Affiliations
University of Nebraska–Lincoln
Brigham and Women's Hospital
United States Department of Agriculture
Harvard University
German Cancer Research Center